Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-55,000
Closed -$3.64M 7626
2017
Q1
$3.64M Sell
55,000
-194,000
-78% -$13.6M ﹤0.01% 2365
2016
Q4
$17.6M Hold
249,000
0.01% 1115
2016
Q3
$14.7M Buy
+249,000
New +$12.2M 0.01% 1155

Other funds holding AGX

UBS Group's AGX Position: Q2 2026 in Review

UBS Group reduced its Argan (AGX) stake by 52% in Q2 2026, selling an estimated $111M and leaving 156,861 shares worth $125M. The position accounts for 0.02% of the portfolio, ranked #972.

UBS Group first reported a position in AGX in Q4 2014 and has held it in 47 quarters since. The position peaked at $176M in Q1 2026. 566 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • UBS Group held 156,861 shares of Argan worth $125M as of Q2 2026.
  • UBS Group sold 167,175 Argan shares in Q2 2026, an estimated $111M.
  • Argan made up 0.02% of UBS Group's portfolio in Q2 2026, its #972 holding.
  • UBS Group first reported a position in Argan in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Argan position peaked at $176M in Q1 2026.
  • 566 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.